229 related articles for article (PubMed ID: 33278965)
41. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
[TBL] [Abstract][Full Text] [Related]
42. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid.
Liu M; Du H; Zhai G
Colloids Surf B Biointerfaces; 2016 Oct; 146():235-44. PubMed ID: 27343846
[TBL] [Abstract][Full Text] [Related]
43. Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Kumar Mehata A; Bharti S; Singh P; Viswanadh MK; Kumari L; Agrawal P; Singh S; Koch B; Muthu MS
Colloids Surf B Biointerfaces; 2019 Jan; 173():366-377. PubMed ID: 30316083
[TBL] [Abstract][Full Text] [Related]
44. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
[TBL] [Abstract][Full Text] [Related]
45. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
46. Fabrication, characterization, and lipid-lowering effects of naringenin-zein-sodium caseinate-galactosylated chitosan nanoparticles.
Zhang H; Liu R; Wang J; Cui SW; Wang S; Wang B; Zhang N; Yang X; Li J; Wang H
Int J Biol Macromol; 2023 Mar; 230():123150. PubMed ID: 36621730
[TBL] [Abstract][Full Text] [Related]
47. Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers.
Liang DS; Su HT; Liu YJ; Wang AT; Qi XR
Biomaterials; 2015 Dec; 71():11-23. PubMed ID: 26310359
[TBL] [Abstract][Full Text] [Related]
48. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
49. Fabrication of curcumin-zein-ethyl cellulose composite nanoparticles using antisolvent co-precipitation method.
Hasankhan S; Tabibiazar M; Hosseini SM; Ehsani A; Ghorbani M
Int J Biol Macromol; 2020 Nov; 163():1538-1545. PubMed ID: 32784024
[TBL] [Abstract][Full Text] [Related]
50. Role of zein incorporation on hydrophobic drug-loading capacity and colloidal stability of phospholipid nanoparticles.
Hong SS; Thapa RK; Kim JH; Kim SY; Kim JO; Kim JK; Choi HG; Lim SJ
Colloids Surf B Biointerfaces; 2018 Nov; 171():514-521. PubMed ID: 30096472
[TBL] [Abstract][Full Text] [Related]
51. Food Protein Based Core-Shell Nanocarriers for Oral Drug Delivery: Effect of Shell Composition on in Vitro and in Vivo Functional Performance of Zein Nanocarriers.
Alqahtani MS; Islam MS; Podaralla S; Kaushik RS; Reineke J; Woyengo T; Perumal O
Mol Pharm; 2017 Mar; 14(3):757-769. PubMed ID: 28103046
[TBL] [Abstract][Full Text] [Related]
52. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
53. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
Mi Y; Zhao J; Feng SS
J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395
[TBL] [Abstract][Full Text] [Related]
54. Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite/Zein nano-drug delivery system for doxorubicin hydrochloride.
Zha L; Wang B; Qian J; Fletcher B; Zhang C; Dong Q; Chen W; Hong L
J Pharm Pharmacol; 2020 Apr; 72(4):496-506. PubMed ID: 31975457
[TBL] [Abstract][Full Text] [Related]
55. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
[TBL] [Abstract][Full Text] [Related]
56. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
57. Enzyme/pH-triggered anticancer drug delivery of chondroitin sulfate modified doxorubicin nanocrystal.
Liang Y; Fu X; Du C; Xia H; Lai Y; Sun Y
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1114-1124. PubMed ID: 32880192
[TBL] [Abstract][Full Text] [Related]
58. Redox/enzyme sensitive chondroitin sulfate-based self-assembled nanoparticles loading docetaxel for the inhibition of metastasis and growth of melanoma.
Liu M; Du H; Khan AR; Ji J; Yu A; Zhai G
Carbohydr Polym; 2018 Mar; 184():82-93. PubMed ID: 29352946
[TBL] [Abstract][Full Text] [Related]
59. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
60. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]